Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
ARWR
↓ PDF (Pro)Arrowhead Pharmaceuticals Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$73.70
-3.52%today
MKT CAP
$11.0B
+11.3% · 1Y
Full Financials
Trailing P/E49.5x
Forward P/E-18.5x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership-
Institutional Ownership-
Short % of Float-
Days to Cover-
1 Week+5.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| AXSM | $11.4B | 49 | - | 37.4 | - | -349.4% | 93% | 402.84 | 0.00% |
| BMRN | $10.5B | 49 | 38.9 | 8.1 | 15.3 | 4.5% | 51% | 23.17 | 0.00% |
| ABVX | $10.0B | 5 | - | - | - | - | - | - | 0.00% |
| EXEL | $12.3B | 80 | 15.3 | 11.5 | - | - | - | - | 0.00% |
| MDGL | $12.4B | 20 | - | 42.3 | - | - | - | - | 0.00% |
| IONS | $12.7B | 41 | - | - | - | -67.6% | 11% | 531.05 | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for ARWR.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.